Creative Biolabs has developed the proprietary Native™ Antibody Discovery Platform to generate these camelid monoclonal antibodies with native characteristic. Based on the antigen-specific B lymphocytes cytometry technology, a great deal of candidate camelid antibodies can be acquired and, more ideally, with native paired heavy-chains. Moreover, these native camelid antibodies have gone through the in vivo affinity maturation which provides higher specificity and affinity than other traditional production techniques and are readily available for subsequent research or single domain antibody development.